News

Samples can be collected from anywhere in India and sent to the National Reference Lab, Rohini, New Delhi, for testingDr Lal PathLabs has introduced Amyloid Typing…

Introduction: Cardiac amyloidosis is an infiltrative cardiomyopathy with high morbidity and mortality, frequently presenting as heart failure (HF) with preserved…

Transthyretin amyloidosis is driving intensive pharmaceutical IP activity across four mechanistically distinct modalities — RNAi silencing, small-molecule…

Transthyretin (ATTR) amyloidosis is a progressive systemic disease associated with substantial morbidity and mortality. Although health-related quality of life (…

The Amyloidosis Research Consortium’s Executive Director of Research, Kristen Hsu, discussed the current clinical trial landscape in AL amyloidosis. She reviewed…

Hereditary transthyretin amyloidosis (ATTRv) is a genetic disorder caused by more than 100 autosomal dominant mutations in the TTR gene. Owing to its marked…

Broad screening criteria of high-risk patients referred for technetium-99m-pyrophosphate (99mTc-PYP) scintigraphy led to a diagnosis of transthyretin-mediated…

Treatment shown to ease symptoms, reduce disability, improve quality of lifeAmvuttra (vutrisiran) safely and effectively eases symptoms, reduces disability,…

Detecting heart failure in its earliest stages has long been a challenge for clinicians, particularly when the cause is a rare and often misdiagnosed protein…

Cardiac MRI tissue characterization can detect early, low-burden transthyretin cardiac amyloidosis and accurately distinguish it from similar conditions, a study…